Exhibit A4. Number of prescriptions identified as disease-related by Prometheus, but not by ETG by National Drug Code (NDC) category.
| CAD | ||
|---|---|---|
| COUNT | PERCENT | |
| major_category1 | 2545 | 4.914 |
| antihyperlipidemic agents | 8278 | 15.982 |
| cardiovascular agents | 6889 | 13.300 |
| gastrointestinal agents | 3527 | 6.809 |
| Analgesics | 3011 | 5.813 |
| Antidepressants | 2771 | 5.350 |
| antidiabetic agents | 2447 | 4.724 |
| beta-adrenergic blocking agents | 2157 | 4.164 |
| Diuretics | 1660 | 3.205 |
| hormones/hormone modifiers | 1502 | 2.900 |
| anti-infectives | 1371 | 2.647 |
| dermatological agents | 1220 | 2.355 |
| respiratory agents | 1203 | 2.323 |
| Bronchodilators | 1069 | 2.064 |
| Penicillins | 1060 | 2.046 |
| Anticonvulsants | 919 | 1.774 |
| nasal preparations | 904 | 1.745 |
| ophthalmic preparations | 851 | 1.643 |
| bone resorption inhibitors | 773 | 1.492 |
| sex hormones | 694 | 1.340 |
| adrenal cortical steroids | 656 | 1.267 |
| anxiolytics, sedatives, andhypnotics | 646 | 1.247 |
| nutritional products | 607 | 1.172 |
| antiarrhythmic agents | 463 | 0.894 |
| Cephalosporins | 460 | 0.888 |
| antiparkinson agents | 437 | 0.844 |
| macrolide derivatives | 400 | 0.772 |
| genitourinary tract agents | 378 | 0.730 |
| metabolic agents | 363 | 0.701 |
| immunosuppressive agents | 313 | 0.604 |
| central nervous system agents | 269 | 0.519 |
| Antineoplastics | 260 | 0.502 |
| miscellaneous agents | 215 | 0.415 |
| Antifungals | 209 | 0.404 |
| muscle relaxants | 161 | 0.311 |
| Anticoagulants | 151 | 0.292 |
| antimalarial agents | 134 | 0.259 |
| Antipsychotics | 121 | 0.234 |
| respiratory inhalant products | 121 | 0.234 |
| antiemetic/antivertigo agents | 115 | 0.222 |
| antiviral agents | 113 | 0.218 |
| otic preparations | 89 | 0.172 |
| antiplatelet agents | 46 | 0.089 |
| topical agents | 46 | 0.089 |
| functional bowel disorderagents | 42 | 0.081 |
| coagulation modifiers | 40 | 0.077 |
| Biologicals | 30 | 0.058 |
| radiocontrast agents | 29 | 0.056 |
| Immunostimulants | 16 | 0.031 |
| antituberculosis agents | 12 | 0.023 |
| vaginal preparations | 3 | 0.006 |
SOURCE: Author’s analysis.